Italian Study Reveals Hidden Risks of Heart Disease in Women

Italian Study Reveals Hidden Risks of Heart Disease in Women

James Myers
James Myers•
• 2 Min.
A map of Europe with varying colors indicating the gender equality index for 2017, accompanied by text on the left side that reads "Gender Equality Index 2017 Health Overview".

Italian Study Reveals Hidden Risks of Heart Disease in Women

A new Italian study is focusing on acute coronary syndromes (ACS) in women, a group often overlooked in heart disease research. The GEDI-ACS registry has begun collecting detailed data from female patients across multiple cardiovascular centres in Italy. Its goal is to improve understanding and treatment of ACS, which remains a leading cause of death worldwide—particularly for women, who face higher mortality risks than men in similar age groups.

The registry plans to enrol 100 consecutive female patients with ACS, ensuring a diverse mix of socioeconomic and cultural backgrounds. Initial findings from the first 68 participants show an average age of 68, with 7.4% identifying as non-Caucasian. A striking 85.3% of these women had low health literacy, highlighting potential barriers to care.

Common risk factors were widespread: 83.6% had dyslipidaemia, 77.9% suffered from hypertension, and half had a history of smoking. Autoimmune diseases affected 32.2% of the group, while anxiety and depression were reported by 42.6%. Pregnancy-related complications also stood out, with 32.3% having experienced miscarriage and 16.2% premature menopause—both known to influence long-term heart health.

For most women (86%), ACS marked their first watch event. Chest pain was the dominant symptom in 88.2% of cases, and 38.2% were diagnosed with myocardial infarction with non-obstructive coronary arteries (MINOCA). Within the first 30 days after the event, outcomes were positive: no deaths, strokes, or repeat heart attacks occurred, though 11.3% still reported recurrent chest pain.

The registry goes beyond standard clinical data. It incorporates sex-specific factors, psychosocial stressors, biochemical markers, and molecular details to develop more precise diagnostic and treatment approaches for women with ACS.

The GEDI-ACS registry's early results underscore the complexity of ACS in women, revealing high rates of risk factors, pregnancy-related complications, and psychosocial burdens. By analysing a broad range of determinants, the study aims to create better-targeted strategies for diagnosis and care. The findings could help reduce the disproportionate mortality risk women face compared to men in similar ACS cases.